Top Markets
#1 Derive Derive +32.37%
#2 Cross Cross +15.42%
#3 Glidr Glidr +10.10%
#4 Gama Token Gama Token +9.10%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +6.92%
#6 Palladium Network Palladium Network +6.09%
#7 Based Based +5.99%
#8 Geodnet Geodnet +5.11%
#9 龙虾 (Lobster) 龙虾 (Lobster) +5.09%
#10 Talus Network Talus Network +4.83%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Coala-Life Group AB (publ) Coala-Life Group AB (publ)

Coala-Life Group AB (publ)

COALA
Rank in Stocks #36346
Coala-Life Group AB (publ) is a medical technology firm that specializes in the... Coala-Life Group AB (publ) is a medical technology firm that specializes in the development, manufacturing, and sale of advanced cardiac diagnostics and mobile health products. The company's flagship offering is the Coala Heart Monitor, a comprehensive medical device and associated service designed for digital remote surveillance, analytical assessment, and personal self-screening of heart conditions. Coala-Life Group AB (publ) was founded in 2004 and maintains its headquarters in Uppsala, Sweden.
Share Price
$0.0019323
Last synced: 2024-07-12
Market Cap
$2.78M
Change (1 day)
16.91%
Change (1 year)
0.00%
Country
SE
Trade Coala-Life Group AB (publ) (COALA)

Category

Healthcare
Revenue for Coala-Life Group AB (publ) (COALA)
Revenue in Aug 2026 TTM: 0
According to Coala-Life Group AB (publ) latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Coala-Life Group AB (publ) from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US